Rate this page:
Poor |
Satisfactory |
Good |
ExcellentPrint/View WholeSend Feedback
Publications Database | Search Publications | Publications Help
Back To Top
Developing drugs for core social and communication impairment in autism.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
Title: Developing drugs for core social and communication impairment in autism.
Year: 2008
Month: October
Volume: 17
Issue: 4
Page(s): pp. 787-801
Abstract: Read Abstract (New Window)
Full Item: Read Full Item (New Window)
Publication Format: Journal Article
Efficacy Study/Review: Yes
Scientific Validity: Selective/Systematic Review, Peer-Reviewed
Keywords: Amantadine Hydrochloride, Anoretic/Anorexigenic, Antidepressants, Antipsychotics, Aripiprazole, Atypical, Autism, Cholinesterase Inhibitors, Communication Skills, Cycloserine, Dextromethorphan, Donepezil, Fenfluramine, Fluoxetine, Fluvoxamine, Galantamine, Glutamate, Hormones, Intervention, Lamotrigine, Medication, Memantine, Mood Stabilisers, Naltrexone, NMDA receptor antagonists, Olanzapine, Opioid Antagonists, Oxytocin, Psychoactive, Quetiapine, Risperidone, Rivastigmine, Secretin, Selective Serotonin Reuptake Inhibitors, Social Skills, Tacrine, Ziprasidone
Please note that Research Autism is unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library, the National Autistic Society's Information Centre (Open in new window) or direct from the publisher.
Publications Database | Search Publications | Publications Help
Back To Top
